key: cord-0844144-9i842zqz
authors: Cline, Abigail; Berk-Krauss, Juliana; Keyes Jacobs, Ashley; Fonseca, Maira; Wu, Julia; Asrani, Falguni; Rizzo, Amilcar; Moy, Janet; Russo, Marian; Glick, Sharon; Blasiak, Rachel; McLellan, Beth N.; Marmon, Shoshana
title: The underrepresentation of “COVID toes” in skin of color: An example of racial bias or evidence of a tenuous disease association?
date: 2020-11-17
journal: J Am Acad Dermatol
DOI: 10.1016/j.jaad.2020.11.003
sha: 188ffb778ac9a50e23af67425cb3af9edd99d337
doc_id: 844144
cord_uid: 9i842zqz

nan

The underrepresentation of ''COVID toes'' in skin of color: An example of racial bias or evidence of a tenuous disease association?

To the Editor: We read with interest the article by Avancini et al 1 describing the absence of cutaneous manifestations associated with coronavirus disease 2019 (COVID-19) in a large, dedicated severe acute respiratory syndrome coronavirus 2 hospital in Brazil. Of the 3982 patients hospitalized with COVID, dermatology was consulted for 98, with no ''COVID toes'' identified among them. Previously, Daneshjou et al 2 published a series of 6 cases (1 positive for COVID) of this pernio-like condition in skin of color, citing a lack of representative imagery in dermatologic literature. This deficiency was subsequently publicized in a New York Times article, suggesting that the dearth of reported cases is related to inadequate training in the recognition of erythematous lesions in dark skin phototypes. 3 Another article in Medscape attributed the scarcity of such findings to entrenched institutionalized racial biases in dermatology. Although the lack of imagery and degree of training in skin of color undoubtedly needs to be addressed, the paucity of documentation of a low-frequency event with a tenuous association to laboratory-confirmed coronavirus infection may not be the best place to begin the discussion.

We previously published a lack of such perniolike diagnoses in 5635 patients treated by dermatology between March and June 2020 in a minoritypredominant safety-net hospital system in New York City. 4 Pangti et al 5 similarly reported that cutaneous manifestations were uncommon in pigmented skin in a series of 138 patients with confirmed COVID-19 diagnoses. Given that the study by Pangti et al 5 was performed in India by Indian dermatologists and the one by Avancini et al 1 in Brazil by Brazilian dermatologists, it is likely they did not have inadequate training in skin of color.

To reevaluate the association of COVID-19 and chilblains in skin of color in our population, we identified all diagnoses of COVID-19, ''pernio,'' ''chilblains,'' and ''vasculitis limited to the skin'' in a retrospective analysis. This study was institutional review board exempt as only unidentifiable, aggregate-level data was used (Slicer/Dicer, Epic, Verona, WI). Between March 1 and August 31, 2020, 19 patients (0.003%) received a diagnosis of chilblains or cutaneous vasculitis, a number (14) and percentage (0.004%) similar to what we found the year before during spring and summer. A larger number of patients, 43 (0.008%), received a diagnosis from September 1, 2019 to February 29, 2020, likely related to the association of this condition with colder weather (Table I) .

After restricting the number to solely patients treated by dermatology from March 1 to August 31, 2020, 12 patients (11 skin of color and 1 white) were identified as having chilblains or cutaneous vasculitis. During this timeframe, 14,649 patients tested positive for COVID-19, of whom 289 (262 skin of color and 27 white) were directly evaluated by dermatology. Since this finding is considered primarily a condition of well individuals, we delineated the number of outpatient visits (280) from inpatient consultations (9). No patients with COVID-19 received a diagnosis of chilblains or cutaneous vasculitis (Table II) . These data, together with the results from our Brazilian and Indian colleagues, suggest that the association of 

Absence of specific cutaneous manifestations of SARS-Cov-2 in a reference center in Brazil

Pernio-like eruption associated with COVID-19 in skin of color

Dermatology has a problem with skin color

COVID toes: phenomenon or epiphenomenon?

Recognizable vascular skin manifestations of SARS-CoV-2 (COVID-19) infection are uncommon in patients with darker skin phototypes

Patients with diagnoses of chilblains/cutaneous vasculitis and COVID-19 evaluated by dermatology Variable Pandemic